Journal · Skin Concerns

Are Lash Serums Safe? Prostaglandin Analogues, Recalls and the EU Ban

Lash serums that work fast usually contain a prostaglandin analogue, a glaucoma-drug relative that the EU's safety committee says is not safe in cosmetics.

Lash serums that deliver fast results usually contain a prostaglandin analogue, a close relative of glaucoma eye drops that pushes lash follicles into their growth phase. EU regulators have concluded these ingredients are not safe in cosmetics, ordered one eyelash serum off sale in August 2026, and proposed banning the whole class.

What Are Prostaglandin Analogues in a Lash Serum?

Key Takeaways

Prostaglandin analogues are glaucoma-drug molecules. They lengthen lashes by acting on the follicle, the way a drug does.
About 30% of lash serums in a 2026 market survey contained one 1.
The EU's safety committee found in February 2026 that none of the three analogues it assessed are safe in lash products 2.
Reported effects include volume loss around the eye, darker eyelid skin and eye irritation, some of which ease after stopping 39.
A draft EU regulation would prohibit the class, with deadlines running from the day it enters into force 8.

A prostaglandin analogue is a synthetic copy of a signaling molecule your body already makes. Ophthalmologists prescribe these as eye drops to lower eye pressure, and longer, darker lashes turned up as a side effect.

That side effect became the product. Serums sold as lash conditioners carry the same molecules, brushed along the lid margin.

Why Do Prostaglandin Analogues Make Lashes Grow?

They work on the hair cycle rather than the hair. Bimatoprost, the best studied of them, raises the percentage of lash follicles sitting in anagen, the active growing phase, at any one time. More follicles growing at once, for longer, reads as longer lashes 6.

The same molecules appear to stimulate melanogenesis, the pigment-making process inside the follicle, which darkens the lash, and to enlarge the hair bulb, which sets how thick a hair grows 6.

None of that is conditioning. Castor oil coats a lash; a prostaglandin analogue instructs a follicle. A molecule potent enough to redirect a hair cycle is doing it a few millimeters from your cornea.

Results arrive slowly, and they do not stay.

Which Ingredient Names Should You Look For?

Name on the label Also written as What it is
Isopropyl cloprostenate Cloprostenol isopropyl ester The substance in the August 2026 EU alert 7
Dechloro dihydroxy difluoro ethylcloprostenolamide Ethyl tafluprostamide, DDDE Rejected by the SCCS 2
Methylamido-dihydro-noralfaprostal MDN Rejected by the SCCS 2
Bimatoprost Norbimatoprost is a relative Prescription glaucoma and lash drug 1

Ethyl tafluprostamide and isopropyl cloprostenate turn up most often 1. Isopropyl cloprostenate and cloprostenol isopropyl ester are one substance under two names, CAS 157283-66-4, and most shoppers have only ever seen one of them.

Reading the list has limits anyway. Blinded reviewers of commercial lash products found the ingredient list frequently made no mention of the analogue inside 3.

What Happened in the August 2026 EU Recall?

On 28 August 2026 the EU's Safety Gate weekly report carried case SR/02358/26, an eyelash serum sold under the brand trucosmetics. Country of origin Cyprus, notified by Germany, logged as a chemical risk at the serious level 7.

The recorded reason: the product contains cloprostenol isopropyl ester, measured value up to 0.003 mg/kg. The alert says the substance should only be used under an ophthalmologist's supervision, flags possible eye and ophthalmic defects, and states it should not be used by pregnant and breastfeeding women because it may affect the child. Retailers were ordered to stop sales 7.

One case in one week. A monthly roundup of these alerts is coming to this blog.

What Side Effects Do Prostaglandin Lash Serums Cause?

Most of the strongest data comes from glaucoma patients, not serum users, so the two are worth keeping apart. Eyelid skin is among the thinnest on your body, which is why change shows there first, as our SPF on lips and eyelids guide explains.

Volume loss around the eye

Prostaglandin-associated periorbitopathy is the clinical name: the upper lid crease deepens and the fat pad shrinks, so the socket looks hollower. It is a well-established effect of the glaucoma drops, which put a far larger dose into the eye than a serum wiped along the lash line does 3.

The one study of cosmetic users graded manufacturers' own before-and-after photographs blind, scoring the prostaglandin group 8.2 out of 19 for signs of volume loss against 2.3 for serums without them 3. Small and informal, built on marketing images.

Its case report is more concrete: a woman in her thirties developed hollowing and thinner, darker lid skin after ten months on a serum containing isopropyl cloprostenate, and it reversed six months after she stopped 3.

Pigment changes and eye irritation

Two pigment stories get conflated. Iris darkening is documented for prostaglandin drops that sit in the eye. For application at the lash line, a review of 50 women who used topical bimatoprost for an average of 4.59 years found no iris color change 4. Eyelid skin darkening is the change that does show up in cosmetic users, and it has faded after stopping 3.

Eye surface irritation is the most common complaint, even under supervision. In a one-year randomized trial of prescription bimatoprost on the lid margin in postchemotherapy patients, 16.7% of participants developed conjunctival hyperemia, reddening of the whites of the eyes, and 9.4% developed punctate keratitis, small dry spots on the cornea 9.

Anything that pushes a follicle into growth does it wherever the product lands 6, so serum migrating onto the lid or cheek can grow hair you did not ask for.

If your eyes are red, sore or light-sensitive, or the shape around the socket is changing, stop and see an ophthalmologist.

What Does the EU Ban Change, and When?

The Scientific Committee on Consumer Safety assessed three analogues at the concentrations manufacturers requested: ethyl tafluprostamide at 0.018%, methylamido-dihydro-noralfaprostal at 0.03%, isopropyl cloprostenate at 0.005%. Its final opinion of 2 February 2026 found none of them safe for growing lashes and brows, citing potent pharmacological activity at low concentrations and missing reproductive toxicity data for a product used mostly by women of childbearing age 2.

On 8 July 2026 the EU notified the World Trade Organization of a draft regulation, notification G/TBT/N/EU/1219, adding prostaglandins and their analogues to Annex II, the prohibited list of the Cosmetic Products Regulation 5.

Two dates get mixed up. 1 February 2027 applies to substances banned over new carcinogenic, mutagenic or reprotoxic classifications, and prostaglandins are not in that group. Under the notified text, products containing them may no longer be placed on the EU market 12 months after the regulation enters into force, nor made available 24 months after 8.

The draft is not adopted, so enforcement runs case by case through alerts like SR/02358/26.

Do Peptide Lash Serums Work Instead?

Prostaglandin analogue Peptide or conditioning
Mechanism Pushes follicles into growth phase 6 Aims to support the follicle; unproven
Evidence Prescription-grade trials 9 Small open-label trials 10
Reported side effects Volume loss, lid darkening, irritation 39 None reported 10
EU status Proposed for prohibition 5 Permitted

Peptide serums do less, and the evidence that they do anything is thin. The best recent example is an open-label trial of a peptide and glycosaminoglycan serum in 30 women: 8.3% more lash length and 10.1% more width at 12 weeks against each woman's own baseline 10. No control group, no blinding, and the authors work for the manufacturer.

Most people will still take that trade.

Patch test on your inner arm and add one new product at a time, so you know what caused a reaction. Keep the eye area protected in daylight, which is what under-eye UV patches and eye SPF are for.

Use This in Your Routine

Skin Bliss is a skincare scanner that checks whether products actually fit your skin, before you buy. For a lash serum the step that matters is the Ingredient List Analyzer: paste or photograph the list in any language and read the breakdown before it goes near your lid margin. The names to find: isopropyl cloprostenate, dechloro dihydroxy difluoro ethylcloprostenolamide, methylamido-dihydro-noralfaprostal. Start at getskinbliss.com.

If the serum joins retinoids or acids near the eye, the Product Compatibility Checker shows what is stacking; our skincare conflict checker guide covers auditing a whole routine.

The Skin Bliss Recall Radar reel goes out weekly with each new batch of EU cosmetics alerts.

Save this before your next lash serum purchase, and read the ingredient list before the marketing copy.

FAQ

Are lash serums safe to use?

Depends on the active. Peptide, panthenol and castor oil serums have no documented periorbital risks and limited evidence of working. Serums with a prostaglandin analogue produce a real effect and carry documented ones. The EU's safety committee concluded that group cannot be considered safe in cosmetics 2.

What are the side effects of prostaglandin lash serums?

Hollowing and fat loss around the eye, darker eyelid skin, a red or dry eye surface, and hair growth wherever the product migrates. In a trial of the prescription version in postchemotherapy patients, 16.7% of participants had reddened whites of the eyes and 9.4% had small corneal dry spots 9. Several effects have reversed after stopping 3.

Is isopropyl cloprostenate banned in the EU?

Not yet. The Commission notified the World Trade Organization on 8 July 2026 of a draft adding prostaglandins and their analogues to the prohibited list 5. Once it enters into force, affected products cannot be placed on the market after 12 months or made available after 24 8. Individual products are already being pulled 7.

Can you use a lash serum while pregnant or breastfeeding?

Not one containing a prostaglandin analogue. The August 2026 EU alert states the substance should not be used by pregnant and breastfeeding women because it may affect the child 7, and the safety committee's central objection was missing reproductive toxicity data 2. Ask your doctor before using any lash product with an active.

Do lashes go back to normal after you stop?

Generally, and fairly quickly, because the effect holds more follicles in the growth phase rather than changing them permanently. Lashes drift back toward their previous length and thickness over a few months. Skin and volume changes around the eye have also improved after stopping, in one case six months later 3.

In your browser

Free Skin Quiz: Understand your skin profile in under 5 minutes

Oily or dry is only the start. Find out what your skin actually needs across six skin dimensions, with a plain note on what each one means for your routine. Results appear in your browser, and you can keep them in the app.

Maria Otworowska, PhD Co-founder of Skin Bliss · PhD in Computational Cognitive Science & AI

Maria combines her background in AI research with a passion for evidence-based skincare. She built Skin Bliss to help people make informed decisions about their skin, backed by science rather than marketing.

Sources (10)
  1. Couteau C, Coiffard L (2026). "Prostaglandin analogues in cosmetic products formulated for eyelash lengthening." *Ann Pharm Fr*.
  2. SCCS (2026). "Opinion on prostaglandin analogues used in cosmetic products (SCCS/1680/25), final version of 2 February 2026." *European Commission, Scientific Committee on Consumer Safety*.
  3. Jamison A et al. (2022). "Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?" *Aesthet Surg J*.
  4. Zaleski-Larsen LA et al. (2017). "Retrospective Evaluation of Topical Bimatoprost and Iris Pigmentation Change." *Dermatol Surg*.
  5. European Commission (2026). "Draft Commission Regulation amending Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances, including those classified as carcinogenic, mutagenic or toxic for reproduction, notified to the WTO as G/TBT/N/EU/1219 on 8 July 2026; recitals 24, 25 and 39." *European Commission, notified draft measure*.
  6. Cohen JL (2010). "Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth." *Dermatol Surg*.
  7. European Commission (2026). "Safety Gate alert SR/02358/26, eyelash serum, weekly report 2026-34 of 28 August 2026." *Safety Gate: the EU rapid alert system for dangerous non-food products*.
  8. European Commission (2026). "Annex to the draft Commission Regulation amending Regulation (EC) No 1223/2009: Annex II entry for prostaglandines and their analogues and its transitional footnote." *European Commission, notified draft measure*.
  9. Wirta D et al. (2015). "Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects." *J Clin Aesthet Dermatol*.
  10. Fernandez-Gonzalez P et al. (2024). "Open clinical trial evaluating the efficacy of a novel eyelash growth enhancer with peptides and glycosaminoglycans." *J Cosmet Dermatol*.